In the first trial of microRNA inhibition to treat heart failure, a novel agent did not reduce left ventricular end-systolic ...
Background Introduction of guideline-directed medical therapy (GDMT) has transformed the care of heart failure (HF) with ...
Transthyretin amyloid cardiomyopathy (ATTR-CM) is an increasingly recognized yet frequently underdiagnosed cause of heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results